MedTrace Logo

National Mobile Asthma Management System-E Project

NCT02917174 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 870

Last updated 2019-06-04

No results posted yet for this study

Summary

Bronchial asthma is a heterogeneous disease characterized by chronic airway inflammation, which is a common and frequently occurring disease in the world, and has resulted in a sustained increase of social and economic burden. However, several studies suggest, lots of asthma patients did not get their asthma controlled. The investigators study showed that in China only 28.7% of asthma patients achieve asthma controlled during 2007-2008. In recent years, application softwares of mobile-phones for asthma have gradually increased, studies suggested that application of these application softwares can make treatment more standard, reduce asthma attacks, help patients to control their asthma, improve adherence and these application softwares also show many other advantages. This study is a prospective, multi center, randomized, controlled study, aims to evaluate the efficacy of application softwares in asthma patients, provide a new tool to asthma management.

Conditions

Interventions

BEHAVIORAL

Mobile Asthma Management System

Patients in this group use a smartphone app in their asthma self-management.

BEHAVIORAL

traditional Asthma Management System

Patients in this group use a printed asthma diary in their asthma self-management.

Sponsors & Collaborators

  • China-Japan Friendship Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-25
Primary Completion
2019-06-01
Completion
2019-06-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02917174 on ClinicalTrials.gov